Contact Us

Technical assets for the CleanCap® technology

Unleash the full potential of CleanCap® capping technology with our curated learning resources. Explore helpful technical notes, insightful white papers, engaging videos, and educational webinars. Deepen your knowledge, hone your skills, and stay ahead of the curve. Embark on your learning journey today with all resources for our CleanCap technology in one place.

Literature

Mice expressing luciferase

Technical note: In vivo mRNA expression

In vivo expression of luciferase mRNA synthesized in vitro with co-transcriptional capping via different cap analogs were compared.

Graphic increase in mRNA yield

Technical note: Enhanced mRNA production

Increasing mRNA yields, without impacting quality attributes, using CleanCap® M6 pulse-feed protocol.

Graph comparing costs of three mRNA capping methods

White paper: Economics of mRNA capping strategies

Qualitative findings on the manufacturing costs of three common methods of mRNA capping are presented.

Capping methods

Technical note: saRNA capping methods

Simplifying manufacturing of alphavirus self-amplifying RNA replicons.

mRNA cap analog under a magnifying glass

Infographic: mRNA capping evolution

Next-generation cap analogs produce Cap-1 structures and allow their incorporation into mRNA in a single in vitro transcription reaction, increasing process efficiency and reducing production time.

Flyer: Increase your mRNA potency

Flyer: Increase your mRNA potency

Gain >30% higher protein expression with our latest CleanCap® M6 analog

Graph representing 9X manufacturing capacity expansion

Case study: A global need meets a large-scale solution

Rapid scale-up manufacturing and analytical testing of CleanCap analogs were achieved to meet timelines and help end the global pandemic.

Flyer Increase your mRNA potency

Poster: Co-transcriptional capping streamlines mRNA manufacturing

CleanCap capping technology is efficient, economical, and high performing.

Video

How does CleanCap® technology work?

Understand co-transcriptional capping vs. post-transcriptional capping and the basics of CleanCap analogs.

How does CleanCap® technology initiate in vitro transcription?

Hear our scientist explain how a CleanCap analog initiates IVT.

What is co-transcriptional capping?

Listen to our Chief Innovation Officer explaining mRNA cap’s functions and co-transcriptional capping.

mRNA caps and CleanCap® technology

Learn about mRNA capping, differences in the mRNA capping methods, and how CleanCap technology can accelerate the development of your mRNA, cell, and gene therapies.

Innovations in CleanCap® technology

Discover our commitment to innovating better versions of CleanCap cap analogs to help our partners come up with better vaccines and treatments.

saRNA capping for vaccine development

Understand considerations for three methods commonly used to cap saRNAs.

Webinars

Evolving_mRNA_landscape

Innovation in mRNA capping and streamlining process development.

Learn how next-generation capping strategies impact manufacturing costs, timelines, and complexity.

mRNA_chemical_modification

mRNA chemical modifications

Explore multiple strategies to improve mRNA functions, including cap, base, and tail modifications for therapeutic applications.

Endogenous_cap

mRNA capping and manufacturing strategies

Gain insights into the functions and properties of mRNAs, and identify how improved capping strategies can benefit mRNA vaccine development.

White paper on the economics of mRNA capping strategies

Clean Cap
Privacy policy
TriLink BioTechnologies does not sell or distribute your information to 3rd parties. For more information, please refer to our Privacy Policy.

CleanCap Technical Note: In vivo mRNA expression

Clean Cap
Privacy policy
TriLink BioTechnologies does not sell or distribute your information to 3rd parties. For more information, please refer to our Privacy Policy.